Table 3 The clinical and demographic information of the participants
Prostate cancer n (%) | BPH n (%) | |
|---|---|---|
Age | ||
< 65 | 49 (53.3) | 43 (46.7) |
65–74 | 36 (48.6) | 38 (51.4) |
≥ 75 | 17 (50.0) | 17 (50.0) |
PSA (ng/ml) | ||
> 10 | 49 (65.3) | 26 (34.7) |
4.1–10 | 43 (43.9) | 55 (56.1) |
4 | 10 (37.0) | 17 (63.0) |
Gleason score | ||
≥ 8 | 33 (100.0) | – |
= 7 | 48 (100.0) | – |
< 7 | 21 (100.0) | – |
Perineural invasion | ||
+ | 71 (100.0) | – |
− | 31 (100.0) | – |